Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Will Maine voters decide to make aging in place affordable?

As Election Day draws near, a ballot initiative in Maine to provide universal home care is shining a spotlight on the inadequacies of the nation's long-term care system.

11 Oct 2018

Researchers develop new techniques for faster detection of Lyme disease bacteria

Researchers have developed techniques to detect Lyme disease bacteria weeks sooner than current tests, allowing patients to start treatment earlier.

11 Oct 2018

NIR spectroscopy could be used to make flu vaccine manufacturing faster and more efficient

Recent research from North Carolina State University outlines how near-infrared spectroscopy could be used to make cell-culture-based flu vaccine manufacturing faster and more efficient.

11 Oct 2018

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Department of Population Health Sciences in the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.

11 Oct 2018

Maternal Tdap immunization during third trimester linked with higher levels of pertussis antibodies in newborns

Risk of whooping cough (pertussis) is highest in infants too young to have completed their primary immunization series (6 months old or younger) and they are at highest risk of developing life-threatening complications.

10 Oct 2018

Research explores whether increasing Medicare payments can improve nursing facility care

Regenstrief Institute and Indiana University Center for Aging Research investigators are testing whether providing nursing homes and the doctors and nurse practitioners who care for their residents with increased Medicare payments can further reduce avoidable hospitalizations.

10 Oct 2018

Study highlights sex differences in 'thermal behavior'

New research from the University at Buffalo has, for the first time, identified differences between men and women in their preferences for maintaining comfort both while exercising and in recovery. The results could one day inform the development of new athletic apparel.

10 Oct 2018

Using state-of-the-art 3D printers to create dissolvable medical implants

As a kid, Michael Sealy was tall. A little clumsy, he says. And he has lasting proof: two metal screws in his left elbow.

9 Oct 2018

Apollo Endosurgery to distribute cold Ensizor Flexible Endoscopic Scissors in select markets

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor® Flexible Endoscopic Scissors in the United States, Europe, and select other markets.

9 Oct 2018

Spurred by convenience, millennials often spurn the ‘family doctor’ model

Calvin Brown doesn’t have a primary care doctor — and the peripatetic 23-year-old doesn’t want one.

9 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

Medicare Advantage plans shift their financial risk to doctors

Dr. Christopher Rao jumped out of his office chair. He'd just learned an elderly patient at high risk of falling was resisting his advice to go to an inpatient rehabilitation facility following a hip fracture.

8 Oct 2018

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

7 Oct 2018

UTMB researchers develop less expensive way to produce vaccines

Researchers at The University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety or effectiveness.

6 Oct 2018

Energy insecure New Yorkers more likely to have many health issues and poor sleep

Nearly one-third of Washington Heights residents surveyed report problems with lack of heat in the winter and/or paying their electric bills.

5 Oct 2018

Scripps Research scientists discover role of immune system double agent

Scientists at Scripps Research have discovered the role of an immune system double agent. This molecule, called USP18, can help curtail immune responses, but it can also open the door to bacterial infections, such as harmful listeria and staph infections.

5 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study showed treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in people at high risk of serious complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

4 Oct 2018

Special glowing paper strip as rapid, reliable test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

3 Oct 2018

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Will Maine voters decide to make aging in place affordable?

Researchers develop new techniques for faster detection of Lyme disease bacteria

NIR spectroscopy could be used to make flu vaccine manufacturing faster and more efficient

Virginia Tech researcher receives $1.7 million to study herpes simplex virus

Maternal Tdap immunization during third trimester linked with higher levels of pertussis antibodies in newborns

Research explores whether increasing Medicare payments can improve nursing facility care

Study highlights sex differences in 'thermal behavior'

Using state-of-the-art 3D printers to create dissolvable medical implants

Apollo Endosurgery to distribute cold Ensizor Flexible Endoscopic Scissors in select markets

Spurred by convenience, millennials often spurn the ‘family doctor’ model

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Medicare Advantage plans shift their financial risk to doctors

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

UTMB researchers develop less expensive way to produce vaccines

Energy insecure New Yorkers more likely to have many health issues and poor sleep

Scripps Research scientists discover role of immune system double agent

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Special glowing paper strip as rapid, reliable test for infectious diseases

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in